Development of an Oncology Elective in a Pharmacy School
Madridge Journal of Pharmaceutical Research
Purpose: The demand for oncology pharmacists has increased since 2008 and about 1% of the nations licensed pharmacists consider themselves board certified oncology pharmacists despite it being the second largest specialty after pharmacotherapy and one of the firsts to develop in the Board of Pharmacy Specialties. The purpose of this paper is to provide information on how an oncology elective in a pharmacy school was developed, what it consisted of and to provide results of student surveys on
... Basic Procedures: The oncology elective was offered to third year pharmacy students in their last term of didactic pharmacy courses. Electives are chosen by students; who are required to take two electives each term in their third year. Topics covered in the elective ranged from double checking a chemotherapy order, making chemotherapy with a closed system transfer device, new drugs, first line treatment articles, oral targeted chemotherapy agents, nutrition for oncology patients to a service learning project that was oncology related. Main Findings and Conclusions: The oncology elective overall received positive feedback. Thirty-two of forty-three students (74.4%) filled out the end of course student evaluation. As rated by the students in the course, overall the mean score of the course was 4.4 out of 5 (88%). Introduction/Background Cancer has been increasing in the United States for the past decade and impacts nearly every American in the United States. There were over 310,000 cancer related deaths in men and over 275,000 cancer related deaths in women in the United States in 2014. The incidence of cancer is expected to increase over the next few decades . Pharmacists play a significant role in oncology in various practice settings. They counsel patients on oral and intravenous chemotherapy medications, assist with writing chemotherapy orders, round with oncologists, prepare and dispense chemotherapy, assist patients with costs of medications, and play a role in oncology research studies. The demand for oncology pharmacists has increased since 2008 and about 1% of the nations licensed pharmacists are Board Certified Oncology Pharmacists (BCOP)  .